Unravelling bladder cancer in Uganda: insights from the discrepancies in TP53 assessment between immunohistochemistry and whole exome sequencing
- 1 March 2025
- journal article
- Published by Medpharm Publications in African Urology
- Vol. 5 (1) , 5-9
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2021
- Positive Ki-67 and PD-L1 expression in post-neoadjuvant chemotherapy muscle-invasive bladder cancer is associated with shorter overall survival: a retrospective studyWorld Journal of Urology, 2020
- Intratumour heterogeneity of p53 expression; causes and consequencesThe Journal of Pathology, 2019
- Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor statusThe Journal of Pathology, 2014
- Comprehensive molecular characterization of urothelial bladder carcinomaNature, 2014
- Biomarkers in bladder cancer: Translational and clinical implicationsCritical Reviews in Oncology/Hematology, 2014
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysisLaboratory Investigation, 2011
- Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological gradeBritish Journal of Cancer, 2007
- p53 mutations in urinary bladder cancerBritish Journal of Cancer, 2001
- p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 bindingOncogene, 1997